Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study

Autor: Coppo, Claudia, Bonfanti, Daria, Bo, Simona, Giordanino, Chiara, Gallo, Monica, Cococcia, Sara, Ciccone, Giovannino, Smedile, Antonina, Ciancio, Alessia, Bugianesi, Elisabetta, Fagoonee, Sharmila, Pellicano, Rinaldo, Rizzetto, Mario, Saracco, Giorgio Maria

Publikováno v: In Digestive and Liver Disease May 2015 47(5):405-410

The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease

Autor: Savarino, Edoardo, Marabotto, Elisa, Zentilin, Patrizia, Frazzoni, Marzio, Sammito, Giorgio, Bonfanti, Daria, Sconfienza, Luca, Assandri, Lorenzo, Gemignani, Lorenzo, Malesci, Alberto, Savarino, Vincenzo

Publikováno v: In Digestive and Liver Disease 2011 43(7):542-547

Clinical Trial: The Association Between Rifaximin And Partially Hydrolyzed Guar Gum Is More Effective Than Rifaximin Alone In Eradicating SIBO

Autor: Furnari , Manuele, Parodi , Andrea, Gemignani , Lorenzo, Giannini , Edoardo G, Marenco , Simona, Savarino , Edoardo, Assandri , Lorenzo, Fazio , Valentina, Bonfanti , Daria, Inferrera , Simona, Savarino , Vincenzo

Publikováno v: Alimentary Pharmacology and Therapeutics
Alimentary Pharmacology and Therapeutics, Wiley, 2010, 32 (8), pp.1000. 〈10.1111/j.1365-2036.2010.04436.x〉

International audience; Background: Abnormal intestinal clearance is involved in the pathogenesis of small intestinal bacterial overgrowth (SIBO). It is known that partially hydrolyzed Guar gum (PHGG) affects intestinal motility. Eradication therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______212::31f2fb3c6cdad4ed8cde2936c303338a
https://hal.archives-ouvertes.fr/hal-00567044/file/PEER_stage2_10.1111%2Fj.1365-2036.2010.04436.x.pdf